8 results on '"Gaztambide, Sonia"'
Search Results
2. Mortality in Acromegaly Diagnosed in Older Individuals in Spain Is Higher in Women Compared to the General Spanish Population.
- Author
-
Biagetti, Betina, Iglesias, Pedro, Villar-Taibo, Rocío, Moure, María-Dolores, Paja, Miguel, Araujo-Castro, Marta, Ares, Jessica, Álvarez-Escola, Cristina, Vicente, Almudena, Álvarez Guivernau, Èlia, Novoa-Testa, Iria, Guerrero Perez, Fernando, Cámara, Rosa, Lecumberri, Beatriz, García Gómez, Carlos, Bernabéu, Ignacio, Manjón, Laura, Gaztambide, Sonia, Cordido, Fernando, and Webb, Susan M.
- Subjects
ACROMEGALY ,MORTALITY ,SOMATOTROPIN - Abstract
Context: There are no data on mortality of acromegaly diagnosed in older individuals. Objective: This work aimed to compare clinical characteristics, growth hormone--related comorbidities, therapeutic approaches, and mortality rate of patients diagnosed before or after 2010 and to assess overall mortality rate compared with the general Spanish population. Methods: A retrospective evaluation was conducted among Spanish tertiary care centers of 118 patients diagnosed with acromegaly at age 65 or older. Kaplan-Meier curves were constructed to trace survival, and Cox proportional hazard models were used to assess the risk factors associated with mortality. We also compared mortality with that of the Spanish population by using age- and sex-adjusted standardized mortality ratios (SMRs). Results: No differences were found in first-line treatment or biochemical control, between both periods except for faster biochemical control after 2010. Twenty-nine (24.6%) patients died, without differences between groups, and had a median of follow-up 8.6 years (103, [72.3] months). Overall SMR was 1.02 (95% CI, 0.57-1.54), (0.60; 95% CI, 0.35-1.06) for men and (1.80; 95% CI, 1.07-2.94) for women. The most common cause of death was cardiovascular disease (CVD). Conclusion: The mortality in patients with acromegaly diagnosed in older individuals was no different between both periods, and there was no overall SMR difference compared with the general Spanish population. However, the SMR was higher in women. As CVD is the leading cause of mortality, it seems advisable to initiate an intense CVD protective treatment as soon as acromegaly is diagnosed, particularly in women, in addition to tight acromegaly control to prevent excess mortality. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
3. Factors associated with therapeutic response in acromegaly diagnosed in the elderly in Spain
- Author
-
Biagetti, Betina, Iglesias, Pedro, Villar-Taibo, Rocío, Moure, María-Dolores, Paja, Miguel, Araújo-Castro, Marta, Ares, Jessica, Álvarez-Escola, Cristina, Vicente, Almudena, Álvarez Guivernau, Élia, Novoa-Testa, Iria, Guerrero Pérez, Fernando, Cámara, Rosa, Lecumberri, Beatriz, García Gómez, Carlos, Bernabéu, Ignacio, Manjón, Laura, Gaztambide, Sonia, Cordido, Fernando, Webb, Susan, Webb, Susan M., Menéndez-Torre, Edelmiro Luis, Díez, Juan J., Simó, Rafael, and Puig-Domingo, Manel
- Subjects
Male ,Human Growth Hormone ,Endocrinology, Diabetes and Metabolism ,Peptides, Cyclic ,Persones grans ,Somatostatin analog ,Somatostatina ,Elderly ,Spain ,Acromegaly ,IGF-1 (insulin-like growth factor 1) ,Humans ,Female ,Surgery ,Receptors, Somatostatin ,Insulin-Like Growth Factor I ,Older people ,Somatostatin ,Growth hormone ,Retrospective Studies - Abstract
ContextSome reports suggest that acromegaly in elderly patients has a more benign clinical behavior and could have a better response to first-generation long-acting somatostatin receptor ligands (SRL). However, there is no specific therapeutic protocol for this special subgroup of patients.ObjectiveThis study aimed at identifying predictors of response to SRL in elderly patients.DesignMulticentric retrospective nationwide study of patients diagnosed with acromegaly at or over the age of 65 years.ResultsOne-hundred and eighteen patients (34 men, 84 women, mean age at diagnosis 71.7 ± 5.4 years old) were included. Basal insulin-like growth factor type 1 (IGF-1) above the upper limit of normal (ULN) and growth hormone (GH) levels (mean ± SD) were 2.7 ± 1.4 and 11.0 ± 11.9 ng/ml, respectively. The mean maximal tumor diameter was 12.3 ± 6.4 mm, and up to 68.6% were macroadenoma. Seventy-two out of 118 patients (61.0%) underwent surgery as primary treatment. One-third of patients required first-line medical treatment due to a rejection of surgical treatment or non-suitability because of high surgical risk. After first-line surgery, 45/72 (63.9%) were in disease remission, and 16/34 (46.7%) of those treated with SRL had controlled disease. Patients with basal GH at diagnosis ≤6 ng/ml had lower IGF-1 levels and had smaller tumors, and more patients in this group reached control with SRL (72.7% vs. 33.3%; p < 0.04) [OR: 21.3, IC: 95% (2.4–91.1)], while male patients had a worse response [OR: 0.09, IC 95% (0.01–0.75)]. The predictive model curve obtained for SRL response showed an AUC of 0.82 CI (0.71–0.94).ConclusionsThe most frequent phenotype in newly diagnosed acromegaly in the elderly includes small adenomas and moderately high IGF-1 levels. GH at diagnosis ≤6 ng/ml and female gender, but not age per se, were associated with a greater chance of response to SRL.
- Published
- 2022
4. Iodine Deficiency and Mortality in Spanish Adults: Di@bet.es Study.
- Author
-
Maldonado-Araque, Cristina, Valdés, Sergio, Badía-Guillén, Rocío, Lago-Sampedro, Ana, Colomo, Natalia, Garcia-Fuentes, Eduardo, Gutierrez-Repiso, Carolina, Goday, Albert, Calle-Pascual, Alfonso, Castaño, Luis, Castell, Conxa, Delgado, Elías, Menendez, Edelmiro, Franch-Nadal, Josep, Gaztambide, Sonia, Girbés, Joan, Chaves, Francisco Javier, Soriguer, Federico, and Rojo-Martínez, Gemma
- Subjects
SPANIARDS ,IODINE deficiency ,NON-communicable diseases ,MEDITERRANEAN diet ,CHRONIC kidney failure ,NUTRITION policy ,CARDIOVASCULAR disease related mortality - Abstract
Background: Longitudinal data assessing the impact of iodine deficiency (ID) on mortality are scarce. We aimed to study the association between the state of iodine nutrition and the risk of total and cause-specific mortality in a representative sample of the Spanish adult population. Methods: We performed a longitudinal observational study to estimate mortality risk according to urinary iodine (UI) concentrations using a sample of 4370 subjects >18 years representative of the Spanish adult population participating in the nationwide study Di@bet.es (2008–2010). We used Cox regression to assess the association between UI at the start of the study (<50, 50–99, 100–199, 200–299, and ≥300 μg/L) and mortality during follow-up (National death registry—end of follow-up December 2016) in raw models, and adjusted for possible confounding variables: age, sex, educational level, hypertension, diabetes, obesity, chronic kidney disease, smoking, hypercholesterolemia, thyroid dysfunction, diagnosis of cardiovascular disease or cancer, area of residence, physical activity, adherence to Mediterranean diet, dairy and iodinated salt intake. Results: A total of 254 deaths were recorded during an average follow-up period of 7.3 years. The causes of death were cardiovascular 71 (28%); cancer 85 (33.5%); and other causes 98 (38.5%). Compared with the reference category with adequate iodine nutrition (UI 100–300 μg/L), the hazard ratios (HRs) of all-cause mortality in the category with UI ≥300 μg/L were 1.04 (95% confidence interval [CI 0.54–1.98]); however, in the categories with 50–99 UI and <50 μg/L, the HRs were 1.29 [CI 0.97–1.70] and 1.71 [1.18–2.48], respectively (p for trend 0.004). Multivariate adjustment did not significantly modify the results. Conclusions: Our data indicate an excess mortality in individuals with moderate-severe ID adjusted for other possible confounding factors. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
5. Population-Based National Prevalence of Thyroid Dysfunction in Spain and Associated Factors: Study.
- Author
-
Valdés, Sergio, Maldonado-Araque, Cristina, Lago-Sampedro, Ana, Lillo, J. Antonio, Garcia-Fuentes, Eduardo, Perez-Valero, Vidal, Gutierrez-Repiso, Carolina, Ocon-Sanchez, Pilar, Goday, Albert, Urrutia, Ines, Peláez, Laura, Calle-Pascual, Alfonso, Bordiú, Elena, Castaño, Luis, Castell, Conxa, Delgado, Elias, Menendez, Edelmiro, Franch, Josep, Gaztambide, Sonia, and Girbés, Joan
- Subjects
THYROID diseases ,DISEASE prevalence ,TRIIODOTHYRONINE ,HYPOTHYROIDISM ,PUBLIC health - Abstract
Background: The aim of this study was to investigate the national prevalence of thyroid dysfunction in Spain and its association with various clinical, environmental, and demographic variables. Methods: The study included 4554 subjects (42.4% men) with a mean age of 50 years (range 18-93 years), who were participants in a national, cross-sectional, population-based survey conducted in 2009-2010. Data gathered included clinical and demographic characteristics, physical examination, and blood sampling. Thyrotropin, free thyroxine, free triiodothyronine, and thyroid peroxidase antibody (TPOAb) concentrations were analyzed by electrochemiluminescence. Urinary iodine (UI) levels were measured in an isolated urine sample. Results: The prevalence of treated hypothyroidism, untreated subclinical hypothyroidism, and untreated clinical hypothyroidism was 4.2% [confidence interval (CI) 3.6-4.9%], 4.6% [CI 4.0-5.2%], and 0.3% [CI 0.1-0.5%], respectively. The prevalence of total hypothyroidism (including all fractions) was 9.1% [CI 8.2-10.0%]. The prevalence of total hyperthyroidism was 0.8% [CI 0.6-1.1]. A total of 7.5% [CI 6.7-8.3%] of the population tested positive for TPOAbs (≥50 IU/mL). In multivariate logistic regression models, TPOAbs were strongly associated with both hypothyroidism ( p < 0.001) and hyperthyroidism ( p = 0.005), whereas high UI levels (>200 μg/g creatinine) were associated with hypothyroidism ( p < 0.001). The positive association between UI and hypothyroidism remained for both treated ( p < 0.001) and untreated ( p < 0.05) hypothyroidism, whereas it was especially significant for non-autoimmune (TPOAbs negative) forms ( p < 0.001). At UI levels ≥200 μg/g, there was a positive correlation between UI and thyrotropin levels (β = 0.152, p < 0.001) and a negative correlation between UI and free triiodothyronine levels (β = −0.134, p = 0.001). Conclusion: According to the data, a large proportion (10%) of the Spanish population has some evidence of thyroid dysfunction. High TPOAb concentrations were associated with both hypo- and hyperthyroidism, whereas high UI concentrations were associated with hypothyroidism. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
6. Low Physical Activity and Its Association with Diabetes and Other Cardiovascular Risk Factors: A Nationwide, Population-Based Study.
- Author
-
Brugnara, Laura, Murillo, Serafín, Novials, Anna, Rojo-Martínez, Gemma, Soriguer, Federico, Goday, Albert, Calle-Pascual, Alfonso, Castaño, Luis, Gaztambide, Sonia, Valdés, Sergio, Franch, Josep, Castell, Conxa, Vendrell, Joan, Casamitjana, Roser, Bosch-Comas, Anna, Bordiú, Elena, Carmena, Rafael, Catalá, Miguel, Delgado, Elias, and Girbés, Juan
- Subjects
DIABETES risk factors ,CARDIOVASCULAR diseases risk factors ,PHYSICAL activity ,SEDENTARY lifestyles ,DISEASE prevalence ,QUESTIONNAIRES - Abstract
Low physical activity (PA), or sedentary lifestyle, is associated with the development of several chronic diseases. We aimed to investigate current prevalence of sedentariness and its association with diabetes and other cardiovascular risk factors. PA was evaluated in a population-based, cross-sectional, randomly sampled study conducted in 2009–2010 in Spain. International Physical Activity Questionnaire (SF-IPAQ) was used to assess PA. 4991 individuals (median age 50 years, 57% women) were studied. Prevalence of sedentariness was 32.3% for men and 39% for women (p < 0.0001). Sex differences were particularly notable (age*sex interaction, p = 0.0024) at early and older ages. Sedentary individuals had higher BMI (28 vs. 27 kg/m
2 ) and obesity prevalence (37 vs. 26%). Low PA was present in 44, 43, and 38% of individuals with known diabetes (KDM), prediabetes/unknown-diabetes (PREDM/UKDM), and normal glucose regulation (p = 0.0014), respectively. No difference between KDM and PREDM/UKDM (p = 0.72) was found. Variables independently associated (p < 0.05) with sedentariness were age, sex, BMI, central obesity, Mediterranean diet adherence, smoking habit, HDL-cholesterol, triglycerides and dyslipidemia. Low PA is on the rise in Spain, especially among women. Sedentariness is associated with several cardiovascular risk factors and may be responsible for the increasing prevalence of obesity and diabetes in this country. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
7. Prevalence, Diagnosis, Treatment, and Control of Hypertension in Spain. Results of the Di@bet.es Study.
- Author
-
Menéndez, Edelmiro, Delgado, Elías, Fernández-Vega, Francisco, Prieto, Miguel A., Bordiú, Elena, Calle, Alfonso, Carmena, Rafael, Castaño, Luis, Catalá, Miguel, Franch, Josep, Gaztambide, Sonia, Girbés, Juan, Goday, Albert, Gomis, Ramón, López-Alba, Alfonso, Martínez-Larrad, María Teresa, Mora-Peces, Inmaculada, Ortega, Emilio, Rojo-Martínez, Gemma, and Serrano-Ríos, Manuel
- Abstract
Copyright of Revista Española de Cardiología (18855857) is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2016
- Full Text
- View/download PDF
8. Low physical activity and its association with diabetes and other cardiovascular risk factors: a nationwide, population-based study
- Author
-
Sonia Gaztambide, Edelmiro Menéndez, Gemma Pascual-Manich, Federico Soriguer, Anna Bosch-Comas, Rafael Carmena, Ramon Gomis, Inmaculada Mora-Peces, Albert Goday, Miguel Catalá, Laura Brugnara, María Teresa Martínez-Larrad, Anna Novials, Joan Vendrell, Emilio Ortega, Josep Franch, Alfonso L. Calle-Pascual, Serafín Murillo, Juan Girbés, Roser Casamitjana, Alfonso López-Alba, Manuel Serrano-Ríos, Elena Bordiú, Gemma Rojo-Martínez, Luis Castaño, Sergio Valdés, Elías Delgado, Conxa Castell, Universitat de Barcelona, [Brugnara,L, Murillo,S, Novials,A, Rojo-Martínez,G, Soriguer,F, Castaño,L, Gaztambide,S, Valdés,S, Vendrell,J, Casamitjana,R, Boch-Comas,A, Carmena,R, Catalá,M, Martínez-Larrad,MT, Pascual-Manich,G, Serrano-Rios,M, Gomis,R] CIBERDEM—Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders, Madrid, Spain. [Brugnara,L, Bosch-Comas,A, Gomis,R] IDIBAPS—August Pi i Sunyer Biomedical Research Institute / Hospital Clínic de Barcelona, Barcelona, Spain. [Rojo-Martínez,G, Valdés,S] Hospital Universitario Carlos Haya, Department of Endocrinology and Nutrition, Málaga, Spain. [Goday,A] Hospital del Mar, Department of Endocrinology and Nutrition, Barcelona, Spain. [Calle-Pascual,A, Bordiú,E] Hospital Universitario San Carlos, Madrid, Spain. [Gaztambide,S] Hospital Universitario de Cruces, UPV-EHU, Diabetes Research Group, Baracaldo, Spain. [Franch,J] EAP Raval Sud, Institut Català de la Salut, Red GEDAPS, IDIAP, Barcelona, Spain. [Castell,C] Public Health Division, Autonomous Government of Catalonia, Barcelona, Spain. [Vendrell,J] Department of Endocrinology and Nutrition, Hospital Universitario Joan XXIII, Tarragona, Spain. [Carmena,R, Catalá,M] Department of Medicine and Endocrinology, Hospital Clínico Universitario de Valencia, Valencia, Spain. [Delgado,E, Menéndez,E] Department of Endocrinology and Nutrition, Hospital Universitario Central de Asturias, Facultad de Medicina y Ciencias de la Salud, Universidad de Oviedo, Oviedo, Spain. [Gilbés,J] Hospital Arnau de Vilanova, Valencia, Spain. [López-Alba,A] Fundación Hospital de Jove, Gijón, Spain. [Serrano-Ríos,M] Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain. [Mora-Peces,I] Canarian Health Service, San Cristóbal de la Laguna, Tenerife, Spain. [Martínez-Larraz,MT, Ortega,E] CIBEROBN - Spanish Biomedical Research Centre in Physiopathology of Obesity. [Ortega,E] Department of Endocrinology and Nutrition, ICMDM, Hospital Clinic Barcelona., This work was supported by the Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM, ISCIII Ministerio de Ciencia e Innovación), Ministerio de Sanidad y Consumo and the Spanish Diabetes Society (SED)., [Brugnara, Laura] CIBERDEM Spanish Biomed Res Ctr Diabet & Associat, Madrid, Spain, [Murillo, Serafin] CIBERDEM Spanish Biomed Res Ctr Diabet & Associat, Madrid, Spain, [Novials, Anna] CIBERDEM Spanish Biomed Res Ctr Diabet & Associat, Madrid, Spain, [Rojo-Martinez, Gemma] CIBERDEM Spanish Biomed Res Ctr Diabet & Associat, Madrid, Spain, [Soriguer, Federico] CIBERDEM Spanish Biomed Res Ctr Diabet & Associat, Madrid, Spain, [Castano, Luis] CIBERDEM Spanish Biomed Res Ctr Diabet & Associat, Madrid, Spain, [Gaztambide, Sonia] CIBERDEM Spanish Biomed Res Ctr Diabet & Associat, Madrid, Spain, [Valdes, Sergio] CIBERDEM Spanish Biomed Res Ctr Diabet & Associat, Madrid, Spain, [Vendrell, Joan] CIBERDEM Spanish Biomed Res Ctr Diabet & Associat, Madrid, Spain, [Casamitjana, Roser] CIBERDEM Spanish Biomed Res Ctr Diabet & Associat, Madrid, Spain, [Bosch-Comas, Anna] CIBERDEM Spanish Biomed Res Ctr Diabet & Associat, Madrid, Spain, [Carmena, Rafael] CIBERDEM Spanish Biomed Res Ctr Diabet & Associat, Madrid, Spain, [Catala, Miguel] CIBERDEM Spanish Biomed Res Ctr Diabet & Associat, Madrid, Spain, [Teresa Martinez-Larrad, Maria] CIBERDEM Spanish Biomed Res Ctr Diabet & Associat, Madrid, Spain, [Pascual-Manich, Gemma] CIBERDEM Spanish Biomed Res Ctr Diabet & Associat, Madrid, Spain, [Serrano-Rios, Manuel] CIBERDEM Spanish Biomed Res Ctr Diabet & Associat, Madrid, Spain, [Gomis, Ramon] CIBERDEM Spanish Biomed Res Ctr Diabet & Associat, Madrid, Spain, [Brugnara, Laura] Hosp Clin Barcelona, IDIBAPS August Pi & Sunyer Biomed Res Inst, Barcelona, Spain, [Murillo, Serafin] Hosp Clin Barcelona, IDIBAPS August Pi & Sunyer Biomed Res Inst, Barcelona, Spain, [Novials, Anna] Hosp Clin Barcelona, IDIBAPS August Pi & Sunyer Biomed Res Inst, Barcelona, Spain, [Casamitjana, Roser] Hosp Clin Barcelona, IDIBAPS August Pi & Sunyer Biomed Res Inst, Barcelona, Spain, [Bosch-Comas, Anna] Hosp Clin Barcelona, IDIBAPS August Pi & Sunyer Biomed Res Inst, Barcelona, Spain, [Pascual-Manich, Gemma] Hosp Clin Barcelona, IDIBAPS August Pi & Sunyer Biomed Res Inst, Barcelona, Spain, [Gomis, Ramon] Hosp Clin Barcelona, IDIBAPS August Pi & Sunyer Biomed Res Inst, Barcelona, Spain, [Rojo-Martinez, Gemma] Hosp Univ Carlos Haya, Dept Endocrinol & Nutr, Malaga, Spain, [Soriguer, Federico] Hosp Univ Carlos Haya, Dept Endocrinol & Nutr, Malaga, Spain, [Valdes, Sergio] Hosp Univ Carlos Haya, Dept Endocrinol & Nutr, Malaga, Spain, [Goday, Albert] Hosp Mar, Dept Endocrinol & Nutr, Barcelona, Spain, [Calle-Pascual, Alfonso] Hosp Univ San Carlos, Madrid, Spain, [Bordiu, Elena] Hosp Univ San Carlos, Madrid, Spain, [Castano, Luis] Univ Basque Country, Hosp Univ Cruces, Diabet Res Grp, Baracaldo, Spain, [Gaztambide, Sonia] Univ Basque Country, Hosp Univ Cruces, Diabet Res Grp, Baracaldo, Spain, [Franch, Josep] IDIAP, Red GEDAPS, Inst Catala Salut, EAP Raval Sud, Barcelona, Spain, [Castell, Conxa] Autonomous Govt Catalonia, Publ Hlth Div, Barcelona, Spain, [Vendrell, Joan] Hosp Univ Joan XXIII, Dept Endocrinol & Nutr, Tarragona, Spain, [Carmena, Rafael] Hosp Clin Univ Valencia, Dept Med & Endocrinol, Valencia, Spain, [Catala, Miguel] Hosp Clin Univ Valencia, Dept Med & Endocrinol, Valencia, Spain, [Delgado, Elias] Univ Oviedo, Hosp Univ Cent Asturias, Fac Med & Ciencias Salud, Dept Endocrinol & Nutr, Oviedo, Spain, [Menendez, Edelmiro] Univ Oviedo, Hosp Univ Cent Asturias, Fac Med & Ciencias Salud, Dept Endocrinol & Nutr, Oviedo, Spain, [Girbes, Juan] Hosp Arnau Vilanova, Valencia, Spain, [Lopez-Alba, Alfonso] Fdn Hosp Jove, Gijon, Spain, [Serrano-Rios, Manuel] Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria, Madrid, Spain, [Mora-Peces, Inmaculada] Canarian Hlth Serv, Tenerife, Spain, [Teresa Martinez-Larrad, Maria] CIBEROBN Spanish Biomed Res Ctr Physiopathol Obes, Pamplona, Spain, [Ortega, Emilio] CIBEROBN Spanish Biomed Res Ctr Physiopathol Obes, Pamplona, Spain, [Ortega, Emilio] Hosp Clin Barcelona, ICMDM, Dept Endocrinol & Nutr, Barcelona, Spain, Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM, ISCIII Ministerio de Ciencia e Innovacion), Ministerio de Sanidad y Consumo, and Spanish Diabetes Society (SED)
- Subjects
Questionnaires ,Male ,Dislipidemias ,Cross-sectional study ,Estudios transversales ,España ,Obesidad ,Índice de masa corporal ,Biochemistry ,Body Mass Index ,0302 clinical medicine ,Endocrinology ,Phenomena and Processes::Musculoskeletal and Neural Physiological Phenomena::Musculoskeletal Physiological Phenomena::Musculoskeletal Physiological Processes::Movement::Motor Activity [Medical Subject Headings] ,Public and Occupational Health ,lcsh:Science ,Phenomena and Processes::Physiological Phenomena::Nutritional Physiological Phenomena::Diet::Diet, Mediterranean [Medical Subject Headings] ,Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Data Collection::Vital Statistics::Morbidity::Prevalence [Medical Subject Headings] ,Chemicals and Drugs::Lipids::Glycerides::Triglycerides [Medical Subject Headings] ,Geographicals::Geographic Locations::Europe::Spain [Medical Subject Headings] ,Aged, 80 and over ,Diabetis ,Diseases::Nutritional and Metabolic Diseases::Metabolic Diseases::Lipid Metabolism Disorders::Dyslipidemias [Medical Subject Headings] ,Phenomena and Processes::Physiological Phenomena::Body Constitution::Body Weights and Measures::Body Size::Body Weight::Overweight::Obesity::Obesity, Abdominal [Medical Subject Headings] ,Cardiovascular Diseases ,Obesitat ,Enfermedades cardiovasculares ,Factores de riesgo ,medicine.medical_specialty ,Endocrine Disorders ,Chemicals and Drugs::Lipids::Lipoproteins::Lipoproteins, HDL::Cholesterol, HDL [Medical Subject Headings] ,Psychiatry and Psychology::Behavior and Behavior Mechanisms::Behavior::Habits::Smoking [Medical Subject Headings] ,Qüestionaris ,Triglicéridos ,Exercici -- Aspectes sanitaris ,03 medical and health sciences ,Diabetes Mellitus ,Humans ,Diseases::Cardiovascular Diseases [Medical Subject Headings] ,Exercise ,Aged ,Survey Research ,Malalties cardiovasculars ,Prevention ,lcsh:R ,Enfermedad crónica ,Biology and Life Sciences ,Physical Activity ,Insulin-resistance ,medicine.disease ,Actividad motora ,Obesity ,Lipid metabolism ,Cross-Sectional Studies ,Dyslipidemia ,Adherence ,Glucosa ,lcsh:Q ,Body mass index ,Demography ,Psychiatry and Psychology::Behavior and Behavior Mechanisms::Psychology, Social::Life Style::Sedentary Lifestyle [Medical Subject Headings] ,Physiology ,Physical fitness ,Sistema cardiovascular -- Malalties ,Chemicals and Drugs::Carbohydrates::Monosaccharides::Hexoses::Glucose [Medical Subject Headings] ,lcsh:Medicine ,Phenomena and Processes::Physiological Phenomena::Body Constitution::Body Weights and Measures::Body Size::Body Weight::Overweight::Obesity [Medical Subject Headings] ,Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Probability::Risk::Risk Factors [Medical Subject Headings] ,Obesidad abdominal ,Geographical Locations ,Glucose Metabolism ,Risk Factors ,Hábito de fumar ,Medicine and Health Sciences ,Prevalence ,030212 general & internal medicine ,Prediabetes ,Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Data Collection::Surveys and Questionnaires [Medical Subject Headings] ,Multidisciplinary ,Diseases::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Disease Attributes::Chronic Disease [Medical Subject Headings] ,Diabetes ,Middle Aged ,Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cross-Sectional Studies [Medical Subject Headings] ,Europe ,Encuestas y cuestionarios ,Physiological Parameters ,Research Design ,Carbohydrate Metabolism ,Female ,Research Article ,Adult ,Adolescent ,030209 endocrinology & metabolism ,Vida sedentaria ,Research and Analysis Methods ,HDL-colesterol ,Young Adult ,Sex Factors ,Diabetes mellitus ,medicine ,Adults ,Espanya ,Diseases::Endocrine System Diseases::Diabetes Mellitus::Prediabetic State [Medical Subject Headings] ,Sedentary lifestyle ,business.industry ,Estado prediabético ,Body Weight ,Dieta mediterránea ,Metabolisme dels lípids ,Diet ,Metabolism ,Spain ,Metabolic Disorders ,People and Places ,Physical therapy ,Sedentary Behavior ,business ,Prevalencia ,Condició física - Abstract
Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM; ISCIII Ministerio de Ciencia e Innovacion); Ministerio de Sanidad y Consumo; Spanish Diabetes Society (SED), Brugnara, L., Murillo, S., Novials, A., Rojo-Martínez, G., Soriguer, F., Goday, A., Calle-Pascual, A., Castaño, L., Gaztambide, S., Valdés, S., Franch, J., Castell, C., Vendrell, J., Casamitjana, R., Bosch-Comas, A., Bordiú, E., Carmena, R., Catalá, M., Delgado, E., Girbés, J., López-Alba, A., Martínez-Larrad, M.T., Menéndez, E., Mora-Peces, I., Pascual-Manich, G., Serrano-Ríos, M., Gomis, R., Ortega, E.
- Published
- 2016
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.